MedPath

A study to evaluate the effects of foods containing indigestible dextrin on the blood glucose elevation inhibitory effect Rondomised,double blind, placebo controlled crossover study

Not Applicable
Conditions
healthy individuals
Registration Number
JPRN-UMIN000038067
Lead Sponsor
Miura Clinic, Medical Corporation Kanonkai
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Subjects with a history of diabetes, liver disease, kidney disease, gastrointestinal disease, peripheral vascular disorder, and other serious diseases (2) Subjects who may have allergic symptoms due to ingredients in the test food (3) Subjects with impaired cardiopulmonary function (4) Subjects with abnormal liver and kidney function test values (5) Subjects who have undergone gastrointestinal surgery (6) Subjects with a disease currently being treated (7) Subjects with food and drug allergies (8) Subjects who have a habit of smoking (9) Subjects who play intense sports and are on a diet (10) Subjects taking food, health foods, quasi-drugs, and pharmaceuticals (including OTC and prescription drugs) that may affect the endpoints of the study (11) Subjects who are excessively consuming alcohol or subjects who cannot ban alcohol from 2 days before the test date (12) Subjects who are pregnant or who are scheduled to become pregnant or breastfeeding during the study period (13) Subjects who are or will be participating in other clinical studies at the start of this study (14) Other subjects deemed inappropriate by the investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood glucose Insulin
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath